Abbott

AbbottAbbott (NYSE: ABT) is a global, broad-based health care company devoted to the discovery, development, manufacture and marketing of pharmaceuticals and medical products, including nutritionals, devices and diagnostics. The company employs more than 68,000 people and markets its products in more than 130 countries. For more information, please visit http://www.abbott.com

Abbott RSS Channel

Filters
List of articles in category Abbott
Title Published Date
Abbott to Acquire Visiogen, Expanding Vision Care Portfolio 03 September 2009
Abbott Reports Strong Second Quarter Results 16 July 2009
Abbott Receives CE Mark for Company's Next-Generation XIENCE PRIME(TM) Drug Eluting Stent 24 June 2009
Abbott's XIENCE V(R) Demonstrates Impressive Results in SPIRIT V Study 22 May 2009
New data to be presented on Abbott's market-leading XIENCE V(R) stent 19 May 2009
Abbott Reports 16 Percent Earnings Growth in First Quarter 17 April 2009
New Data for Abbott's TRILIPIX(R) (fenofibric acid) in Combination with Rosuvastatin Calcium 30 March 2009
The Lancet Publishes Two-Year Results of Abbott's Fully Bioabsorbable Drug Eluting Stent 13 March 2009
Abbott Successfully Completes Tender Offer for Shares of Advanced Medical Optics 25 February 2009
Abbott Receives EC Clearance on Acquisition of Advanced Medical Optics 22 February 2009
Abbott Reports Double-Digit Sales and Earnings Growth in Fourth Quarter 21 January 2009
Abbott Introduces RealTime Molecular Assay in Europe for Detection of HPV Infection 13 January 2009
Abbott Announces Earnings Guidance for 2009 12 January 2009
Abbott Opens New Research Facility and Pilot Plant in Ludwigshafen 10 October 2008
Abbott’s HUMIRA® (adalimumab) Approved in the European Union 12 September 2008